FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns medicine, namely pharmacology, hypoglycemic agents influencing the glucose blood content in treating the diseases associated with metabolic disorders, such as pancreatic diabetes. The agent expressing hypoglycemic activity, characterised by that it contains N-isopropylamide-2-(1-phenylethyl)aminoethanesulphacid hydrochloride in effective amount.
EFFECT: invention renders more expressed hypoglycemic action.
2 cl, 3 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
ANTIDIABETIC AGENT | 1998 |
|
RU2150952C1 |
ISONICOTINOYLHYDRAZIDE PHTHALATE AS ANTIDIABETIC AGENT | 2006 |
|
RU2331418C2 |
APPLICATION OF VACCINIUM AXILLARE NAKAI SHOOTS AS MEDICATION, DEMONSTRATING ACTIVISATION OF GLUCOSE UTILISATION BY BRAIN IN TREATMENT OF DIABETES MELLITUS | 2007 |
|
RU2418602C2 |
METHOD OF OBTAINING MEDICINE WITH HYPOGLYCEMIC EFFECT | 2006 |
|
RU2332225C2 |
PREPARATIONS OF ANTIHYPOXIC PROPERTIES | 2002 |
|
RU2232576C2 |
AGENT FOR TREATMENT OF PATIENT WITH DIABETES MELLITUS | 1996 |
|
RU2139718C1 |
AGENT WITH HYPOGLYCEMIC EFFECT, OBTAINED FROM RASPBERRY RHIZOMES AND ROOTS | 2022 |
|
RU2793328C1 |
MEANS FOR TREATING DIABETES | 2000 |
|
RU2165767C1 |
ANTIDIABETIC AGENT | 2001 |
|
RU2197259C1 |
Authors
Dates
2010-04-10—Published
2008-10-23—Filed